hrv
positivesens
singlestrand
ribonucl
acid
rna
virus
icosahedr
symmetri
capsid
compos
four
protein
insid
viru
anchor
rna
core
viral
capsid
complet
sequenc
known
hrv
genom
serotyp
hrv
identifi
hrv
serotyp
hrva
hrvb
famili
use
intercellular
adhes
major
group
cell
receptor
viru
entri
hrv
use
heparin
sulfat
proteoglycan
addit
receptor
approxim
serotyp
use
lowdens
lipoprotein
cell
receptor
minor
group
new
clade
hrv
report
label
although
hrvc
strain
character
genom
sequenc
receptor
use
infect
epitheli
cell
current
unidentifi
replic
rna
genom
serv
mrna
encod
capsid
structur
protein
well
nonstructur
cell
entri
viral
genom
translat
polyprotein
undergo
proteolyt
cleavag
produc
structur
nonstructur
gene
product
serotyp
hrv
base
amino
acid
differ
four
capsid
protein
enterovirus
ev
typic
thought
caus
acut
respiratori
tract
infect
howev
properti
ev
hrv
independ
identifi
hrv
serotyp
associ
respiratori
ill
multipl
hrv
infect
initi
involv
upper
respiratori
tract
deposit
hrv
eye
nose
viru
attach
host
cell
epithelium
infect
nasal
epitheli
cell
result
increas
neutrophil
detect
nasal
mucosa
secret
releas
inflammatori
mediat
although
hrv
replic
best
found
lower
respiratori
tract
cell
temperatur
hrv
produc
cytopatholog
chang
howev
hrv
appear
disrupt
tight
junction
cell
lead
increas
vascular
leakag
mucu
secret
use
primari
nasal
epitheli
cell
hrv
found
alter
function
express
cystic
fibrosi
transmembran
conduct
regul
cftr
sodium
channel
sodium
channel
sodium
channel
find
may
help
explain
mechan
alter
mucociliari
clearanc
associ
hrv
infect
symptom
follow
hrv
infect
ascrib
host
respons
viru
includ
mediat
innat
mucos
cellular
immun
system
follow
epitheli
cell
attach
intern
hrv
infect
result
cytokin
express
includ
type
type
iii
interferon
ifn
interleukin
il
neutrophil
recruit
result
releas
growth
factor
chemokin
vpi
bind
major
target
memori
immun
respons
resid
subclass
iga
class
antibodi
major
antibodi
direct
ntermin
peptid
pla
locat
insid
capsid
antibodi
respons
hrv
human
appear
misdirect
nonneutr
epitop
expos
uncoat
group
children
asthma
upper
respiratori
infect
uri
type
iii
level
significantli
higher
wheez
children
infect
hrv
compar
nonwheez
although
type
iii
level
lower
baselin
children
asthma
compar
healthi
children
found
hyperexpress
asthma
exacerb
addit
studi
report
antivir
antiinflammatori
properti
primari
epitheli
cell
asthmat
patient
expos
recent
publish
mous
model
hrv
infect
adult
mice
enhanc
type
immun
respons
attenu
type
respons
compar
neonat
author
report
longterm
mucos
metaplasia
airway
respons
hrvinfect
neonat
mice
addit
found
increas
express
epitheli
neonat
rhinoviru
infect
appear
mediat
metaplasia
airway
hyperrespons
hrvinfect
neonat
mice
induct
type
cytokin
tumor
necrosi
diminish
neonat
compar
adult
mice
hrv
infect
elicit
increas
respons
neonat
mice
observ
may
help
understand
intersect
earli
hrv
infect
subsequ
develop
asthma
hrv
caus
respiratori
ill
throughout
world
age
group
throughout
year
although
preval
fall
spring
temper
one
studi
hrv
account
approxim
common
hrv
commonli
infect
children
earli
childhood
adulthood
schoolag
children
frequent
introduc
hrv
infect
home
secondari
attack
rate
rang
daycar
center
school
also
import
locat
spread
hrv
hrv
transmiss
occur
close
contact
autoinocul
fomit
aerosol
clinic
outcom
appear
similar
hrv
speci
recent
identifi
hrvc
infect
symptom
common
cold
pharyng
croup
aom
bronchiol
andor
infect
report
healthi
children
adult
well
asthma
immunocompromis
condit
cf
multipl
hrvc
hrva
bs
major
caus
wheez
infant
asthma
exacerb
older
virus
detect
middl
ear
fluid
children
otiti
media
hrvc
account
half
document
although
report
infect
come
mainli
respiratori
tract
specimen
hrvc
rare
report
blood
sensit
polymeras
chain
reaction
pcr
method
hrv
detect
sever
report
long
period
week
hrv
posit
strain
type
use
howev
hrv
shed
normal
stop
within
day
therefor
persist
may
repres
serial
overlap
infect
multipl
untyp
immunocompromis
children
hrvc
strain
detect
threefold
longer
vs
day
immunocompet
recent
studi
document
hrv
speci
month
year
tropic
subtrop
semiarid
mani
hrvc
strain
found
circul
singl
year
may
detect
subsequ
standard
tissu
cultur
method
isol
use
detect
hrv
infect
sensit
develop
pcr
techniqu
abil
detect
respiratori
virus
increas
significantli
detect
hrv
respiratori
specimen
enhanc
revers
transcriptionpcr
rtpcr
involv
use
hybrid
probe
doublestrand
dna
bind
dye
sever
studi
found
increas
sensit
rtpcr
compar
viral
cultur
antibodi
assay
report
hrv
readili
avail
help
clinic
sinc
common
antigen
hrv
serotypespecif
neutral
antibodi
assay
necessari
detect
rise
serum
antibodi
follow
acut
infect
larg
number
hrv
serotyp
make
approach
impract
incub
period
common
cold
hour
rhinorrhea
sneez
plu
nasal
congest
usual
initi
sore
throat
common
may
earli
symptom
fever
unusu
headach
malais
often
mild
resolut
symptom
occur
almost
case
within
day
use
pcr
techniqu
hrv
report
commonli
asymptomat
may
result
prolong
shed
previou
respiratori
ill
mild
ill
went
unrecogn
new
viru
infect
incub
period
asymptomat
hrv
shed
common
adult
appear
children
addit
coinfect
respiratori
virus
respiratori
ill
well
global
spread
influenza
seri
surveil
protocol
activ
monitor
character
pandem
mani
countri
report
find
patient
influenzalik
ill
ili
respiratori
specimen
test
wide
rang
respiratori
virus
report
use
pcr
techniqu
children
adult
tabl
percentag
specimen
posit
hrv
rang
studi
influenza
ill
could
distinguish
hrvrelat
ill
clinic
characterist
influenza
outbreak
respiratori
virus
especi
hrv
continu
caus
signific
case
uri
lower
respiratori
infect
lri
asthma
exacerb
children
adult
frequent
associ
respiratori
viru
infect
especi
hrv
infect
lead
sever
longerlast
lower
respiratori
tract
lower
airway
dysfunct
follow
hrv
infect
may
result
direct
infect
lower
airway
stimul
inflammatori
immunolog
neurogen
mechan
upper
airway
therebi
impact
lower
airway
hrv
detect
columnar
basal
cell
layer
lower
use
situ
hybrid
replic
strand
hrv
lower
airway
experiment
hrv
infect
asthmat
subject
demonstr
airway
narrow
marker
eosinophil
activ
bronchial
infiltr
eosinophil
cell
cell
activ
prostaglandin
leukotrien
pathway
induct
nitric
innat
immun
respons
found
defect
bronchial
epitheli
cell
obtain
asthmat
subject
impair
respons
hrv
found
peripher
blood
mononuclear
cell
reflect
significantli
lower
level
higher
level
asthmat
patient
compar
normal
healthi
sever
studi
found
defici
induct
hrv
bronchial
epitheli
cell
asthmat
induct
mrna
significantli
reduc
asthmat
compar
nonasthmat
subject
bronchoalveolar
cell
asthma
patient
defici
hrv
ad
studi
support
view
innat
immun
respons
asthmat
subject
defici
two
ifn
famili
sever
lung
cell
type
respons
hrv
infect
hrv
infect
major
caus
wheez
episod
infant
wheez
episod
infanc
viru
induc
often
associ
asthma
develop
children
hrv
infect
result
hospit
infanc
recent
implic
earli
predictor
subsequ
develop
almost
wheez
children
year
studi
asthma
diagnos
year
age
outpati
hrv
wheez
ill
infanc
also
found
predictor
wheez
year
possibl
relationship
hrv
wheez
ill
genet
risk
childhoodonset
asthma
studi
group
prospect
studi
particip
children
studi
sinc
birth
cultur
hrv
children
hrv
wheez
ill
signific
associ
gene
locu
multipl
longitudin
studi
document
import
respiratori
viral
infect
acut
exacerb
chronic
obstruct
pulmonari
diseas
copd
studi
use
pcr
techniqu
respiratori
viru
detect
found
copd
exacerb
associ
respiratori
virus
especi
hrv
inflammatori
mediat
especi
found
increas
level
respiratori
secret
obtain
stabl
copd
patient
studi
demonstr
increas
staphylococcu
aureu
streptococcu
pneumonia
adher
respiratori
epitheli
cell
infect
hrv
vitro
studi
use
primari
differenti
human
cell
cultur
line
strain
nontyp
haemophilu
influenza
found
potenti
airway
epitheli
cell
respons
hrv
increas
tolllik
howev
unclear
whether
interact
respiratori
viru
bacteri
pathogen
common
caus
exacerb
copd
whether
respiratori
virus
hrv
caus
pulmonari
complic
virus
especi
hrv
result
inflammatori
reaction
result
mucociliari
damag
impair
middl
ear
function
increas
mucu
eustachian
tube
lead
superinfect
middl
ear
bacteria
fluid
accumul
effus
recent
studi
detect
hrv
children
otiti
media
hrv
cultur
nasopharyng
specimen
prospect
studi
otitispron
children
nasopharyng
swab
assay
pcr
respiratori
virus
cultur
bacteri
pathogen
hrv
found
baselin
specimen
posit
pcr
test
hrv
correl
cultur
moraxella
catarrhali
pneumonia
nontyp
h
influenza
hrv
bacteri
pathogen
found
otitispron
children
even
absenc
clinic
symptom
new
otiti
media
episod
coincid
hrv
url
recent
publish
studi
south
african
children
aom
case
respiratori
virus
detect
middl
ear
fluid
hrv
detect
children
aom
respiratori
virus
recov
episod
neg
bacteri
cultur
hiv
statu
alter
spectrum
respiratori
virus
recov
patient
common
cold
syndrom
sinu
abnorm
detect
comput
abnorm
frequent
detect
maxillari
ethmoid
sinus
resolv
without
antibiot
patient
follow
sever
week
less
case
viral
rhinosinus
complic
bacteri
studi
adult
acut
rhinosinus
viru
cultur
posit
hrv
posit
use
rtpcr
maxillari
sinu
aspir
nasal
intranas
pressur
increas
follow
nose
blow
sneez
cough
high
enough
propel
virusinfect
nasal
reaction
multipl
studi
use
pcr
assay
shown
hrv
caus
communityacquir
pneumonia
cap
children
studi
children
report
rang
posit
specimen
hrv
tabl
bronchiol
children
commonli
report
infant
young
children
commonli
report
viru
recov
acut
case
rsv
cap
seri
mix
infect
second
respiratori
viru
common
studi
test
respiratori
virus
adult
cap
hrv
detect
case
tabl
mani
case
cap
mix
infect
difficult
certain
hrv
contribut
cap
studi
examin
role
respiratori
viral
infect
cf
picornaviru
detect
uri
children
underli
differ
pulmonari
function
children
proven
hrv
infect
versu
respiratori
virus
smyth
et
al
follow
patient
cf
year
detect
hrv
patient
proven
hrv
infect
show
deterior
clinic
activ
receiv
day
intraven
antibiot
goffard
et
al
report
sampl
adult
patient
hrv
frequent
identifi
cf
patient
clinic
exacerb
identifi
ramirez
et
al
found
similar
hrv
detect
cf
patient
exacerb
measur
increas
chemokin
express
sputum
sampl
hrvposit
respiratori
viru
infect
common
caus
acut
respiratori
ill
patient
solidorgan
transplant
follow
bone
marrow
immunocompromis
patient
hrv
number
one
detect
respiratori
viru
pcr
assay
ison
et
al
found
fatal
rate
hematopoiet
stem
cell
transplant
patient
bronchoalveolar
lavag
bal
posit
sampl
studi
patient
underli
hct
infect
day
incid
hrv
median
durat
viru
shed
week
hrv
infect
associ
uri
symptom
prospect
studi
patient
malign
neutropenia
viru
detect
hrv
common
viru
detect
quantit
pcr
nasopharyng
aspir
prospect
multicent
studi
children
cancer
fever
neutropenia
viru
detect
pcrdna
third
patient
mix
hrvbacteri
hrv
second
detect
viru
rsv
frequent
identifi
signific
morbid
mortal
posttranspl
patient
report
follow
hrv
bone
marrow
transplant
recipi
fever
uri
symptom
hrv
commonli
detect
respiratori
hospit
outbreak
hrv
infect
report
neonat
intens
care
unit
icu
longterm
care
one
studi
neonat
acquir
hrv
infect
hospit
longterm
care
facil
hrv
outbreak
occur
potenti
death
associ
infect
guidelin
hospit
isol
recommend
droplet
precaut
patient
known
hrv
approv
antivir
medic
hrv
respiratori
tract
infect
anticholinerg
medic
use
rhinorrhea
nasal
congest
allevi
nasal
system
decongest
sever
studi
suggest
heat
humidifi
steam
may
reduc
nasal
congest
common
cold
data
cough
common
accompani
problem
respiratori
viral
infect
suppress
nonprescript
cough
suppress
symptom
sore
throat
myalgia
fever
headach
control
nonsteroid
antiinflammatori
drug
antibiot
inappropri
treat
viral
infect
compound
target
cell
suscept
viru
attach
receptor
blockag
viru
uncoat
rna
replic
viral
protein
synthesi
evalu
although
sever
agent
demonstr
vitro
vivo
success
none
receiv
us
food
drug
administr
approv
due
poor
bioavail
poor
sideeffect
profil
limit
viral
capsidbind
compound
pleconaril
block
viru
uncoat
clinic
trial
demonstr
signific
reduct
durat
respiratori
symptom
individu
receiv
pleconaril
drug
approv
altern
medic
echinacea
angustifolia
zinc
lozeng
test
sever
volunt
trial
current
thought
clinic
studi
suffer
inadequ
control
group
incomplet
virolog
evalu
quinolon
use
treat
exacerb
copd
broad
antibacteri
spectrum
antiinflammatori
properti
recent
levofloxacin
found
inhibit
hrv
infect
primari
cell
cultur
employ
human
tracheal
epitheli
levofloxacin
pretreat
decreas
mrna
level
macrolid
also
report
reduc
express
hrvinduc
cytokin
vitro
recent
random
control
studi
evalu
clinic
benefit
oral
prednisolon
treat
first
episod
hrvassoci
wheez
young
children
younger
longterm
benefit
demonstr
children
receiv
oral
prednisolon
first
hrvassoci
wheez
episod
shortterm
benefit
found
receiv
oral
prednisolon
includ
less
cough
rhiniti
nighttim
respiratori
symptom
subset
children
high
viral
load
copiesml
longterm
benefit
prednisolon
therapi
detect
futur
studi
confirm
find
gener
recommend
made
corticosteroid
treatment
asthmapron
children
hrvassoci
wheez
episod
hrv
recov
hand
approxim
adult
cold
handtohand
transmiss
hrv
led
evalu
disinfect
elimin
viru
human
skin
trial
reduc
hand
transmiss
report
differ
recent
publish
studi
bangladesh
demonstr
nasal
swab
sampl
pair
hand
rins
sampl
hrv
detect
rrtpcr
sampl
studi
use
aqueou
iodin
decreas
transmiss
famili
member
expos
hrvinfect
individu
evalu
virucid
hand
treatment
confirm
prevent
hrv
infect
organ
acid
hand
wash
soap
water
effect
clean
hrvcontamin
hand
better
singl
treatment
ethanol
hand
vaccin
thought
use
hrv
serotypespecif
neutral
antibodi
produc
follow
infect
numer
howev
recent
studi
mous
model
report
develop
crossserotyp
reactiv
antibodi
suggest
basi
success
antibodymedi
vaccin
develop
futur
studi
need
confirm
expand
preliminari
observ
coronavirus
posit
singlestrand
rna
virus
replic
cytoplasm
bud
cytoplasm
vesicl
endoplasm
reticulum
coronavirus
divid
three
group
alpha
beta
gamma
human
aminopeptidas
n
cellular
receptor
tabl
recent
studi
shown
newli
report
use
receptor
cell
entri
along
sever
acut
respiratori
syndrom
sar
cov
use
angiotensinconvert
enzym
entri
found
ciliat
nasal
tracheobronchi
epitheli
cell
receptor
known
carcinoembryon
antigen
cea
receptor
mous
hepat
phylogenet
relationship
coronavirus
base
deduc
amino
acid
sequenc
coronaviru
replicas
gene
middl
east
respiratori
syndrom
mer
cov
belong
genu
betacoronaviru
bcov
famili
first
lineag
c
sixth
coronaviru
known
infect
human
merscov
envelop
positivesens
singlestrand
rna
viru
replic
cycl
similar
cov
host
cell
receptor
merscov
protein
dipeptidyl
receptor
express
endotheli
epitheli
cell
kidney
lung
small
intestin
liver
well
immun
cell
abil
infect
mani
differ
organ
cell
may
explain
extrapulmonari
clinic
characterist
patient
uncoat
translat
orfab
follow
transcript
genom
replic
follow
translat
rough
er
bud
assembl
virion
occur
cytoplasm
exocytosi
virion
releas
sarscov
receptor
upon
sarscov
infect
express
lung
markedli
downregul
therefor
help
explain
sar
pathogenesi
progress
acut
respiratori
distress
syndrom
tabl
coronavirus
attach
cellular
receptor
spike
protein
intern
host
cell
occur
direct
fusion
plasma
membran
endocytosi
posttransl
proteolyt
process
import
regulatori
mechan
polyprotein
cleav
viral
proteas
facilit
assembl
subunit
protein
complex
respons
replic
littl
inform
host
respons
coronaviru
replic
humor
immun
respons
detect
follow
natur
infect
role
cellmedi
immun
larg
sever
vitro
vivo
differ
sarscov
merscov
infect
radiograph
differ
well
differ
cytopath
effect
host
respons
infect
appear
differ
exampl
observ
differ
sensit
type
ifn
vitro
merscov
sensit
type
ifn
compar
sar
pathogenesi
control
part
innat
immun
signal
sarscov
encod
protein
modul
innat
immun
signal
antagon
ifn
induct
avoid
ifnstimul
gene
effector
function
tabl
coronavirus
detect
agent
respiratori
infect
approxim
year
later
identifi
coronavirus
label
accept
new
genu
epidemiolog
studi
adult
coronavirus
estim
caus
adult
common
cold
coronavirus
found
caus
epidem
everi
year
reinfect
common
age
suscept
epidemiolog
studi
coronavirus
found
associ
respiratori
ill
usual
upper
respiratori
tract
occasion
caus
pneumonia
temper
climat
transmit
primarili
winter
link
asthma
copd
exacerb
children
three
close
relat
coronaviru
speci
isol
girl
coryza
conjunct
fever
bronchiol
epidemiolog
studi
patient
rang
age
month
year
highest
infect
rate
occur
age
year
use
molecular
probe
target
conserv
region
coronaviru
genom
relat
coronaviru
hcovnh
found
young
children
test
rtpcr
respiratori
specimen
prospect
studi
hong
kong
coronavirus
detect
patient
admit
hospit
sign
symptom
acut
respiratori
infect
patient
posit
posit
posit
posit
peak
winter
month
upper
respiratori
tract
ill
common
present
infect
infect
occur
earli
summer
fall
winter
use
newer
molecular
assay
group
vanderbilt
reassess
role
newli
describ
coronavirus
larg
cohort
healthi
children
follow
prospect
lri
sampl
avail
screen
posit
result
hcov
younger
year
aom
found
half
hcovinfect
children
none
children
hospit
uri
sampl
test
detect
hcov
rna
fiftyon
percent
posit
children
diagnos
aom
burden
uri
attribut
hcov
signific
yeartoyear
variat
recent
studi
provid
evid
genet
variabl
complet
nucleotid
sequenc
two
contemporari
strain
compar
prototyp
strain
atcc
vr
demonstr
import
amino
acid
substitut
potenti
cleavag
site
sequenc
spike
protein
first
case
sar
report
guangdong
provinc
next
month
countri
report
case
patient
approxim
fatal
patient
acquir
sar
guangdong
travel
hong
kong
thought
index
case
half
case
differ
known
human
anim
coronavirus
dna
sequenc
new
coronaviru
cultur
himalayan
palm
civet
thought
bat
primari
reservoir
fig
sar
infect
peopl
result
death
mer
epidemiolog
origin
implic
dromedari
camel
sourc
human
case
fig
first
confirm
case
requir
hospit
comorbid
medic
condit
common
male
like
identifi
infect
median
age
year
secondari
case
commonli
identifi
younger
health
care
worker
incub
period
day
rang
day
mortal
rate
report
approxim
may
two
case
merscov
infect
unit
state
report
center
diseas
control
prevent
cdc
patient
acquir
infect
work
health
care
saudi
arabia
contact
patient
develop
infect
merscov
coronavirus
requir
special
cell
line
organ
cultur
detect
cultiv
cell
organ
cultur
techniqu
labor
intens
time
consum
rel
insensit
coronavirus
also
detect
rtpcr
greater
sensit
standard
cultur
sarscov
initi
detect
rtpcr
cultur
viral
rna
found
high
level
fece
sar
patient
confirm
sarscov
infect
criteria
requir
detect
viral
rna
pcr
increas
antibodi
titer
bodi
fluid
isol
sarscov
clinic
laboratori
diagnost
method
sarscov
includ
viral
rna
detect
use
rtpcr
immunofluorosc
antibodi
ifa
elisa
viru
isol
less
sensit
method
requir
biosafeti
level
facil
antibodi
assay
report
coronavirus
readili
avail
help
clinic
complementfix
elisa
antibodi
assay
coronavirus
publish
avail
clinic
therefor
serolog
test
antibodyspecif
respons
mainli
reserv
research
epidemiolog
studi
serolog
assay
complement
nucleic
acid
detect
assay
sarscov
help
identifi
sourc
infect
transmiss
pattern
analysi
patient
contact
studi
diagnos
asymptomat
case
even
number
assay
avail
sar
mer
outbreak
differenti
hcov
serolog
mean
remain
problem
viral
neutral
test
remain
specif
assay
avail
limit
laboratori
anim
virolog
data
surveil
studi
support
theori
mer
origin
bat
africa
cross
speci
barrier
infect
camel
mani
year
ago
infect
camel
transport
middl
east
transmit
merscov
human
recent
report
show
complet
genom
sequenc
viru
isol
dromedari
camel
ident
human
strain
isol
sick
human
develop
mer
follow
close
contact
sick
mode
transmiss
camel
human
current
unknown
although
droplet
transmiss
seem
like
laboratori
confirm
mer
requir
nucleic
acid
amplif
assay
criteria
confirm
case
includ
rtpcr
two
differ
specif
target
rtpcr
one
specif
target
plu
addit
differ
rtpcr
product
sequenc
confirm
merscov
requir
viral
cultur
neutral
antibodi
detect
assay
prospect
studi
respiratori
viral
infect
among
hospit
patient
coronavirus
coronaviru
infect
repres
respiratori
viral
infect
patient
coronavirus
associ
anoth
respiratori
viru
lower
respiratori
tract
infect
bronchiti
bronchiol
pneumonia
far
common
upper
respiratori
tract
rhiniti
pharyng
laryng
infect
versu
respect
half
infect
due
strain
approxim
due
strain
approxim
due
coronaviru
infect
first
year
life
associ
predominantli
strain
hcov
identifi
specimen
hospit
adult
patient
lower
respiratori
tract
frequent
identifi
isol
follow
specimen
mani
patient
highrisk
underli
condit
sever
recent
studi
evalu
multiplex
pcr
assay
hcov
detect
hospit
children
younger
year
acut
respiratori
patient
sar
present
fever
cough
andor
myalgia
dyspnea
hypoxemia
note
second
week
ill
rapidli
progress
respiratori
failur
occur
subset
patient
patient
appear
contagi
lower
respiratori
tract
sign
nonspecif
present
symptom
common
merscovinfect
patient
fever
chill
sore
throat
frequent
respiratori
tract
symptom
also
quit
common
within
day
symptom
respiratori
failur
develop
chest
radiograph
find
progress
unilater
focal
lesion
extens
multifoc
bilater
involv
specif
merscov
common
ct
find
bilater
often
basilar
airspac
involv
cavit
report
late
ct
find
recov
patient
may
includ
fibrot
chang
organ
pneumonia
acut
renal
failur
often
observ
second
week
ill
mer
viru
also
seen
small
percentag
sar
patient
dialysi
often
requir
nonrespiratori
tract
involv
report
includ
diarrhea
patient
nausea
vomit
pericard
complic
mer
includ
superinfect
coinfect
septic
shock
delirium
icu
care
often
need
within
day
admiss
casefat
rate
rang
case
identifi
asymptomat
mild
case
identifi
predominantli
young
healthi
women
without
signific
comorbid
publish
random
control
trial
specif
antivir
agent
treatment
sar
mer
support
therapi
current
recommend
plan
renal
failur
occur
renal
dialysi
necessari
mechan
ventil
icu
often
requir
sever
candid
antivir
agent
identifi
includ
ifn
ribavirin
cyclophilin
vitro
cell
cultur
experi
anim
studi
shown
antivir
activ
agent
merscov
howev
human
case
receiv
combin
ribavirin
corticosteroid
surviv
prompt
isol
suspect
sar
mer
case
contact
trace
case
contact
key
prevent
nosocomi
standard
contact
droplet
precaut
use
case
airborn
precaut
employ
aerosolgener
procedur
bronchoscopi
tracheostomi
airway
insert
vaccin
design
sarscov
merscov
focus
develop
chimer
spike
glycoprotein
contain
neutral
epitop
multipl
strain
within
across
inclus
nucleocapsid
protein
chimer
vaccin
could
broaden
protect
respons
protein
major
determin
protect
immun
antibodi
protein
appear
protect
sarscov
challeng
anim
studi
n
proteinspecif
immun
respons
provid
littl
protect
crossreact
within
subgroup
thu
approv
vaccin
mer
cov
use
convalescentphas
plasma
immun
globulin
high
titer
neutral
antibodi
evalu
random
control
hrv
hcov
caus
signific
morbid
immunocompet
peopl
patient
underli
chronic
immunosuppress
medic
condit
newer
diagnost
test
expand
understand
respiratori
virus
clinic
infect
sensit
diagnost
test
use
detect
new
hrv
hrvc
recent
studi
pathogenesi
hrv
host
respons
group
virus
provid
insight
potenti
target
therapeut
intervent
recent
outbreak
sar
mer
pose
special
problem
treatment
infect
vaccin
develop
hcov
andor
coronavirus
appear
mani
year
away
